Positive and Negative Syndrome Scale as a long-term outcome measurement tool in patients receiving clozapine ODT- A Pilot Study

نویسندگان

  • Gollapudi Shankar
  • Carmen Nate
چکیده

OBJECTIVE This pilot, twelve-week, open-label study examined the effect of clozapine orally disintegrating tablet or ODT in patients with schizophrenia and schizoaffective disorder utilizing Positive and Negative Syndrome Scale (PANSS) as a long-term outcome measurement tool. METHODS The final study sample consisted of nineteen subjects who were residents a long-term care psychiatric facility in Pomona, California. Subjects were using clozapine ODT (FazaClo®) at the most clinically effective dosage depending on their symptoms and at the discretion of the psychiatrist and psychopharm consultant. PANSS were administered at baseline, week-4, week-8 and week-12. Paired sample t-tests were used to calculate the statistical significance of the mean differences for scores at baseline and week-12. RESULTS Mean differences from baseline indicated significant improvement on total score, as well as positive, negative, cognitive and general psychopathology subscales after twelve weeks of treatment. The greater average reduction in the negative syndrome subscale across the twelve weeks possibly illustrates the ability of clozapine ODT in improving negative symptoms, including cognitive function which is their ability to participate in their personal care and creative expressions in dance, arts, games, poetry to a greater extent their overall, quality of life and living along with the effect on positive symptoms. CONCLUSION Overall, clozapine proved to affect a broad range of psychopathology including cognitive functions in this schizophrenic sample.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

کلوزاپین: انقلابی جدید در درمان شیزوفرنی

Clozapine is the first antipsycotic drug with a great efficacy. Thirty to fifty percent of treatment-resistant schizophrenics markedly improved with clozapine. Approximately, 25% of long-term patients, treated with clozapine, could be discharged. This improvement included negative as well as positive symptom areas. Clozapine produced no extrapyramidal side effects. Tardive dyskinesia, a major s...

متن کامل

مقایسه اثر کلوزاپین و ضدپسیکوزهای کلاسیک بر فشار و سلامت روانی مراقبان بیماران مبتلا به اسکیزوفرنیا

 AbstractIntroduction: Due to the effect of symptoms of patients with schizophrenia on the psycholo-gical well-being of their caregivers, this study was carried out to assess the effect of treatment with clozapine and conventional antipsychotics on the caregivers’ burden and well-being. Method: Two hundred and three patients with schizophrenia and their caregivers were examined in a retrospecti...

متن کامل

اثر افزودن نالترکسون در درمان اسکیزوفرنیا: مقایسه دو سوکور با دارونما

 AbstractIntroduction: Given the role of opioids and their antagonists on dopamine secretion, the effect of naltrexone use in the treatment of schizophrenia was evaluated in this study. Method: In a double blind placebo controlled clinical trial study on a group of 34 patients with schizophrenia on maintenance therapy with antipsychotics, 17 patients received naltrexone (50 mg, BID) and 17 pati...

متن کامل

Low Dose Celecoxib Combined with Clozapine for Treatment of Schizophrenia: A Double Blind Randomized Clinical Trial

Introduction: Higher levels of pro-inflammatory cytokines in schizophrenia have suggested that dysfunctions of the immune system may play a role in this disabling condition. The current study was performed to discover if low dose celecoxib combined with clozapine may improve symptoms of schizophrenia or not. Methods:<span...

متن کامل

Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary Evidence

Recently, extensive efforts have been made to understand the rate of energy expenditure and the weight gain associated with atypical antipsychotic treatment, including identification of markers of obesity risk. In recent years, leptin, an adipocyte hormone, has gained significant interest in psychiatric disorders. S100B has been considered as a surrogate marker for astrocyte-specific damage in ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2007